Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. - Wikidata - wikimedia - TriplyDB

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

http://www.wikidata.org/entity/Q34553328

about

Progress of stem/progenitor cell-based therapy for retinal degeneration The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives.Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology.Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors.Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells.Clinical, Biochemical, and Genetic Aspects of Sjögren-Larsson Syndrome.Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.Immunological Issues After Stem Cell-Based β Cell Replacement.Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D.Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart Muscle Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics.New Models for Therapeutic Innovation from Japan.Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization.Surgically Induced Focal Retinal Detachment Does Not Cause Detectable SD-OCT Retinal Changes in Normal Human Retina Cell Therapy for Parkinson's Disease.The pigmented epithelium, a bright partner against photoreceptor degeneration.Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes.Detection of Retinal Pigment Epithelium-Specific Antibody in iPSC-Derived Retinal Pigment Epithelium Transplantation Models.ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors.Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.Human stem cell-derived retinal epithelial cells activate complement via collectin 11 in response to stress.Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method.Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks.Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.Regenerative medicine for the esophagus.Stem cells and genome editing: approaches to tissue regeneration and regenerative medicine.Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.Beta-cell replacement strategies for diabetes.Autologous stem cell therapy for inherited and acquired retinal disease.Analysis of mitochondrial function in human induced pluripotent stem cells from patients with mitochondrial diabetes due to the A3243G mutation.The utility of stem cells in pediatric urinary bladder regeneration.Production and rearing of germ-free X-SCID pigs.Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.Stem cell biology and regenerative medicine for neonatal lung diseases.Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes.Advances in stem cells and regenerative medicine: single-cell dynamics, new models and translational perspectives.Induced pluripotent stem cell-based therapy for age-related macular degeneration.When Long Noncoding RNAs Meet Genome Editing in Pluripotent Stem Cells.Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation.Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice-Manufactured Human Induced Pluripotent Stem Cell Line.

P2860

Q33655064-B5728569-F1D2-446D-88F1-E8F4F628A2F6 Q33753295-9039808D-DC6C-4175-AF72-3B9E35C21813 Q33768195-6FFF3614-178B-4783-9F6F-29A926A91700 Q38685965-13F281EF-ADDB-42CB-A4A7-5B0D5AB04656 Q39235894-6FC71D67-46D5-49D8-A66F-9B4858B0E720 Q39329372-B51A175C-EE6E-40A3-94F0-1D89513A61DC Q39423311-D969F28B-6323-4702-85E0-1F45E115E62F Q39446999-94C7E200-1AC6-4DAD-BB92-6A83F3DD6B0D Q40054588-7B09DA0B-3A4D-439C-AE99-B74DF1CA87A3 Q41417860-937DF71D-513F-4BFB-B04E-BE8AE46059A2 Q41537754-61F153E9-72FF-4A69-BEA4-1260C96DB025 Q42016113-125C6899-A70A-4F66-815F-9E5C0653DC81 Q42172254-166D4A95-3A46-4E46-B46F-49F38AC97D9C Q42379453-FEF03CA3-F321-44D8-B2EC-7ECEAB31B495 Q45740164-45DD6411-1B7F-40F5-9E21-3F90151CEAB5 Q45874106-923AF744-D3AC-498C-8774-7301861E7246 Q45874302-E6E9A1DA-2F53-42D7-BF78-419940FFD667 Q46084992-41D56480-17AD-472A-AB85-2C818E2C1576 Q46315708-9384839C-2EC1-4B1F-A5F2-30284739758A Q46350666-D40EE9EC-B2C4-4664-9823-30634642933D Q47136064-A70A1730-274E-47DE-9D51-4B675751DBAB Q47147498-573ABACC-C52B-4453-A1D3-595A27A6F6FA Q47197637-1571B1C1-F0D3-414B-8DB5-D1B85EC3DA89 Q47210326-1EF32B95-FBEF-43F9-AD10-507DC245E3C6 Q47274655-8781061B-E33C-49C0-B55C-5D711B16DFE3 Q47563945-52EEA3F8-766C-4DA9-8237-47BB53CF8677 Q47574712-29DB9601-5E44-485A-8779-FC253B1C05C5 Q47596092-D96B5834-7E9C-4CF2-8831-01C6568E203D Q47649236-5F69FF8B-0A5C-4951-A086-5FBB65627D46 Q47654465-0F40401F-4717-47C4-903C-B46232B9B68A Q47670436-D87D6AA7-EC41-43EA-893F-D92B64E57AF9 Q47703697-F06571CD-6F90-4680-ABEF-0C1C9CF795D7 Q47708333-9FA1A18A-EDFA-4F35-83B8-588C7F538DDB Q47785486-BFF9603D-04BD-4B9D-91C8-08203F69D073 Q47909800-AE5EC0A8-718D-49B7-ACED-E0C8889E4EAA Q48160366-0CBF2BEA-383C-45A1-9545-88C69783EB60 Q48218214-227A7C4A-922F-4195-8095-730D65520DB6 Q48247374-BEF38873-44B2-4D31-A613-286A51081296 Q48352444-6D9675DF-2AE3-46F2-B708-B5C1AF26090E Q48365947-B2EA54D8-28B2-4887-850E-5FBD3BE42983

P2860

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

http://www.wikidata.org/entity/Q34553328

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@ast

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@en

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@nl

type

label

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@ast

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@en

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@nl

prefLabel

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@ast

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@en

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

@nl

P1433

Q34553328-AA6CFB08-DD81-44F8-97D0-8BB712E535F1

P1476

Q34553328-954D3E7E-3E93-4DA5-BB68-50EF35C44A61

P2093

Q34553328-05A768A1-BEFF-4A31-9CD1-6FA4F452F09F

Q34553328-077639F5-7014-4FD5-9BD2-76851275951E

Q34553328-0F6659A8-72D3-443D-A1D6-88FED47FD360

Q34553328-1E085844-047C-4EF7-A2E1-F284EFA8B424

Q34553328-2A012BDF-3FD5-4E5B-9B85-5902FB1E5F57

Q34553328-2B521969-0E80-4303-A91B-E3B6E1B302D9

Q34553328-2D83C134-0895-4E74-8EC3-04DAF35B4461

Q34553328-396AD197-5FBF-45B6-B6D0-679CED2C1D1E

Q34553328-39884CA0-91D3-4F8D-BC0A-8A37B7C2EAAD

Q34553328-3BCFCFC9-D220-45B8-B483-D2641490E6A8

P304

Q34553328-8577C29F-DB1F-4757-AA16-9FADFA0ABFC4

P31

Q34553328-AC8C878F-0792-4154-A464-861944A7410B

P356

Q34553328-2C4F0163-BA07-4638-BDEA-DE556F59A27A

P407

Q34553328-CEB580B4-7E55-47D1-AAA4-E35EA403CEAE

P433

Q34553328-A8DD1670-4157-4230-866E-603708D1E888

P478

Q34553328-23697327-F485-4CC4-A54A-5EFC52CA7F6E

P50

Q34553328-74C1BFF2-E71D-4940-B5D0-4965761ABA55

Q34553328-ECB03C0D-D794-4311-9FC2-01A5332E2825

Q34553328-F7E18A82-526A-416F-80AC-F726BC43039A

P577

Q34553328-DC2AF49A-2471-48ED-B504-187FDE933FA7

P698

Q34553328-11115847-261D-4F50-952E-879634A95EC7

P356

P1433

The New England Journal of Medicine

P1476

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration

@en

P2093

Akira Watanabe

http://www.w3.org/2001/XMLSchema#string

Akishi Onishi

http://www.w3.org/2001/XMLSchema#string

Chihiro Okada

http://www.w3.org/2001/XMLSchema#string

Chikako Morinaga

http://www.w3.org/2001/XMLSchema#string

Chikara Shinohara

http://www.w3.org/2001/XMLSchema#string

Fumiyo Kitaoka

http://www.w3.org/2001/XMLSchema#string

Hiroshi Akimaru

http://www.w3.org/2001/XMLSchema#string

Junko Kuwahara

http://www.w3.org/2001/XMLSchema#string

Kanako Fujita

http://www.w3.org/2001/XMLSchema#string

Ken-Ichiro Hata

http://www.w3.org/2001/XMLSchema#string

P304

1038-1046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1608368

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

376

http://www.w3.org/2001/XMLSchema#string

P50

Kenichi Yoshida

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28296613

http://www.w3.org/2001/XMLSchema#string